drugset / Trial / NCT00463736

Magnesium Sulfate Versus Placebo for Tocolysis in PPROM

NCT00463736

Terminated 4 enrolled Regional Obstetrical Consultants
RandomizedParallel-groupOpen-labelTreatment

Summary

Study compares the outcomes of women between 26 and 32 wks gestation with rupture of membranes. Women randomized to receive tocolysis with magnesium sulfate x 48 hrs or placebo of saline IV x 48 hrs. Antibiotics and antenatal steroids given to both groups.

Timeline

Start
2007-04
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Magnesium Sulfate Other / unclassified 2 g Intravenous